Find clinical trials for Triple Negative Breast Cancer in Chicago, IL
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Triple Negative Breast Cancer trials near Chicago, IL, USA:
Assess response to pembrolizumab in both primary tumor, normal breast stroma, circulating lymphocytes and serum exosomes in treatment naive ...
Phase 1
Maywood, Illinois, United States and 2 other locations
doxorubicin (PLD, Doxil) are safe and effective at controlling the cancer in patients with metastatic triple negative breast...
Phase 1
Chicago, Illinois, United States and 5 other locations
This research study involves testing the safety and efficacy of an investigational intervention for patients with triple-negative b ...
Phase 2
Chicago, Illinois, United States and 9 other locations
or paclitaxel (cohort 1) or with sacituzumab govitecan-hziy (cohort 2) in patients with non-surgically removable locally advanced or metastatic triple...
Phase 2
Skokie, Illinois, United States and 44 other locations
The purpose of this study is to determine if a combination of two drugs ipatasertib and atezolizumab works as a treatment for residual cancer...
Phase 2
Chicago, Illinois, United States and 8 other locations
and to evaluate the efficacy of this combination in advanced HER2 negative breast cancer that is triple negative...
Phase 1, Phase 2
Chicago, Illinois, United States and 4 other locations
in patients with unresectable, locally advanced or metastatic triple-negative breast cancer (TNBC) who received a...
Phase 2
Joliet, Illinois, United States of America and 21 other locations
This is a 3-arm study stratified by plasma ctDNA. Patients with residual TNBC disease after pre-operative therapy will be assigned to 1 of 3 Arms bas...
Phase 2
Chicago, Illinois, United States and 12 other locations
This pilot study will provide preliminary data regarding the role of PIS in predicting the benefit of immune checkpoint inhibition with or without ch...
Phase 2
Chicago, Illinois, United States and 3 other locations
This trial studies ladiratuzumab vedotin (LV) with pembrolizumab in patients with triple-negative breast cancer. -...
Phase 1, Phase 2
Maywood, Illinois, United States and 49 other locations
Clinical trials
Research sites
Resources
Legal